Article info
Co-stimulatory molecules
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases
- Correspondence to:
Dr R L Wilder;
wilderr{at}medimmune.com
Citation
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases
Publication history
- First published November 1, 2002.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Annals of the Rheumatic Diseases